The FDA has approved GSK’s Exdensur (depemokimab-ulaa) as an add-on maintenance therapy for adolescents and adults with severe asthma characterized by an eosinophilic phenotype. 1 ...

The FDA has approved Exdensur for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in patients aged 12 and older.

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...

May is Asthma Awareness Month, and May 2 is Asthma Awareness Day. This year’s theme is debunking myths and misinformation about asthma. There are many ways you can get involved. Share on Pinterest ...

For a long time, doctors thought of asthma as just one disease. But they now realize there’s more to the story. They’ve started to think of asthma like a collection of conditions, with differences ...

What Is an Asthma Attack? An asthma attack is a sudden worsening of asthma symptoms caused by the tightening of muscles around your airways. This tightening is called a bronchospasm. During the asthma ...

asthma, lungs Authors review changes in the diagnosis, workup, and treatment of asthma in the 2022 GINA report. Some patients with asthma who lack evidence of type 2 inflammation are considered to ...

At least two area school districts were already prepared for a new law that requires districts to have a plan in place for asthma emergencies, superintendents say. “I think it’s something that’s ...

Research has underscored the effects of exposure and sensitization to allergens on the severity of asthma in inner-city children. It has also revealed the limitations of environmental remediation and ...

Housing quality is a primary determinant of asthma disparities by race and social class in the US. We sought to assess how housing code enforcement systems in Boston, Massachusetts, address tenants’ ...